Bioequivalence and Bioavailability Forum • Rivastigmine 6 mg: patients?

Rivastigmine 6 mg: patients? [Design Issues]

posted by drmuneesh – 2009-08-22 08:51 (6155 d 17:15 ago) – Posting: # 4092
Views: 7,848

Dear Helmut

Some of the links are given below. These studies were for european submission.
http://www.emea.europa.eu/humandocs/PDFs/EPAR/rivastigmine_teva/H-1044-en6.pdf
http://www.emea.europa.eu/humandocs/PDFs/EPAR/nimvastid/H-1029-en6.pdf

Regards
Muneesh

Complete thread:

BE study of Rivastigmine 6 mg in healthy volunteers drmuneesh 2009-08-21 10:59
- Rivastigmine 6 mg: patients? Helmut 2009-08-21 23:17
  - Rivastigmine 6 mg: patients?drmuneesh 2009-08-22 06:51
    - Rivastigmine 6 mg (EU centralised procedure) Helmut 2009-08-22 13:56
    - Rivastigmine 6 mg: patients? ElMaestro 2009-08-22 17:47
      - EMEA at its best Helmut 2009-08-22 18:37
        
        EMEA at its best ElMaestro 2009-08-22 19:17
        
        EMEA at its best drmuneesh 2009-08-24 13:59
        
        EMEA at its best drcampos 2009-08-24 19:26
        
        EMEA at its best drmuneesh 2009-08-25 06:12
        
        Rivastigmine BE Dr Lalit 2009-08-25 14:41
        
        Rivastigmine BE drmuneesh 2009-08-26 06:29

Admin contact
23,656 posts in 4,994 threads, 1,570 registered users;
258 visitors (0 registered, 258 guests [including 16 identified bots]).
Forum time: 02:06 CEST (Europe/Vienna)

It requires a very unusual mind
to undertake the analysis of the obvious. Alfred North Whitehead

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz